NCCAM, NIAID Investigating Antiviral Efficacy Of Nominated CAM
This article was originally published in The Tan Sheet
Executive Summary
A new Preclinical Antiviral Testing Program for Complementary & Alternative Medicine (PATP-CAM) seeks to "systematically and rigorously investigate CAM approaches to prevent or treat [viral] infections," the National Center for Complementary & Alternative Medicine states in an Aug. 28 notice
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning